Calendar Korro Bio, Inc.

Equities

KRRO

US5009461089

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
62.93 USD +7.52% Intraday chart for Korro Bio, Inc. -5.71% +31.30%

Chart calendar Korro Bio, Inc.

4edcb5992979a8586aee2d.FT9t_O8ziNk-Ikj_hufalHZ7ZPRpdPDa98YapJ6oHTg.Zgs4t4NB8rdfGgbG5IyP3wY2FLYkEb-DjvB05ffsS0pBXD6Kjkv99ApACQ~020e63020ce5e98f06f444a4225d7763

Upcoming events on Korro Bio, Inc.

2024-05-13 12:30 pm Citizens JMP Life Sciences Conference
2024-05-14 10:00 am RBC Capital Markets Global Healthcare Conference
2024-05-15 11:15 am BofA Securities Health Care Conference

Past events on Korro Bio, Inc.

2024-04-15 Piper Sandler Spring Biopharma Symposium
2024-04-08 01:30 pm Needham Healthcare Conference
2024-03-26 04:01 pm Q4 2023 Earnings Release
2024-03-04 02:10 pm TD Cowen Health Care Conference
2024-01-09 02:15 pm JPMorgan Healthcare Conference
2023-11-02 Annual General Meeting - M&A Vote
2023-08-10 04:01 pm Q2 2023 Earnings Release
2023-07-14 08:30 am Korro Bio and Frequency Therapeutics Inc Merger Call
2023-05-17 Q1 2023 Earnings Release (Projected)
2023-03-13 08:00 am Oppenheimer Healthcare Conference
2023-03-10 07:30 am Q4 2022 Earnings Release
2023-03-08 12:50 pm Cowen Health Care Conference
2022-12-13 08:00 am Business Update Call
2022-11-20 Q3 2022 Earnings Release (Projected)
2022-09-14 12:50 pm Baird Global Healthcare Conference
2022-09-13 05:00 pm American Academy of Otolaryngology Head and Neck Surgery Meeting
2022-09-13 11:00 am H.C. Wainwright Global Investment Conference
2022-08-09 04:05 pm Interim 2022 Earnings Release
2022-06-21 09:00 am Annual General Meeting
2022-05-24 07:00 am H.C. Wainwright Global Life Sciences Investment Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-84,5
-73,9
-14.46%

-85,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-58,0


-81,1
-73,7
-10.12%

-83,6

Net income
Million USD
Released
Forecast
Spread
-58,0


-81,2
-74,3
-9.3%

-83,6

EPS
USD
Released
Forecast
Spread
0,00


-53,1
-12,0
-340.86%

-9,54

Announcement Date27/07/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-26,9
-22,3
-20.67%

-21,0


-21,8


-22,0


-22,3


-21,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-25,4
-18,2
-39.63%

-20,0


-20,8


-21,2


-21,6


-21,0

Net income
Million USD
Released
Forecast
Spread
-25,4
-18,2
-39.78%

-20,0


-20,8


-21,2


-21,6


-21,0

EPS
USD
Released
Forecast
Spread
-43,1
-2,36
-1723.7%

-2,51


-2,57


-2,63


-2,69


-2,66

Announcement Date26/03/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. KRRO Stock
  4. Calendar Korro Bio, Inc.